Meanwhile, people with overweight or obesity lost up to 11.3% more weight than placebo by week 36 with a novel GLP-1 agonist ...

People who brought their blood glucose down to a normal level had a lower risk of death from heart disease or hospitalization ...

Continuous glucose monitoring may have a role in identifying and preventing diabetes among healthy adults, but more studies ...

At the San Antonio Breast Cancer Symposium, researchers reported that real-time monitoring with smart pill bottles ...

In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen ...

Giredestrant, a selective estrogen receptor antagonist and degrader given as an adjuvant therapy, shows significant ...

Ultraprocessed foods and single-used plastic bottles contain chemicals that may drive inflammation in hidradenitis ...

Thyroid disorders, common endocrine conditions, often require long-term management. Shivkumar Aggarwal, seeking lasting ...

Patients with hormone receptor (HR)-positive, HER2-negative advanced breast cancers had similar progression-free survival (PFS) whether they were treated with sacituzumab govitecan-hziy (Trodelvy) or ...

Erika Mayer, MD, MPH, Dana-Farber Cancer Institute, discusses the exciting findings of the phase 3 lidERA study investigating ...

An international research team led by the Medical University of Vienna has shown that continuous glucose monitoring (CGM) in ...